Evidence map›Paper›PMID 42620561›Full record

ArticleFrontiers in oncology2026

Brachytherapy-based multimodality cancer treatment: a concept and design perspective on devices to address the challenges of localized radiation therapy.

Joshua J Herskovic, Arnold M Herskovic

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joshua J HerskovicDepartment of Surgery, Baptist Health South Florida, Boynton Beach, FL, United States.
Arnold M HerskovicDepartment of Radiation Oncology (Emeritus), Rush University Medical Center, Chicago, IL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To present a family of novel brachytherapy-based device concepts that address the geometric, dosimetric, and integrative limitations of current localized radiation therapy, aiming to improve local tumor control while reducing collateral exposure. This is a concept and design paper, not a clinical or dosimetric validation study. Methods: Multiple device designs were developed over more than a decade, focused on two prototypical clinical settings: intraluminal applicators for the esophagus and intracavitary applicators for the post-resection glioblastoma cavity. Designs include hollow rectangular ribbon (HRR) catheters that encase fluid, gel, or wire isotope sources; modified stents with anti-slippage geometry, dynamic flares, and reservoirs; and a multifunctional cavity device combining brachytherapy with continuous hyperthermia and pressure-modulated diffusional drug, immunotherapy, and nanoparticle delivery. Bench prototypes were constructed and evaluated. Results: Bench observations demonstrated manipulation of a thermal gradient by modulating the warm source, and an approximately 15-fold increase in dislodgement force for a representative anti-slippage geometry. The designs are further intended to flatten the near-surface dose gradient by expanding the effective source distribution and to integrate drainage, infusion, and pressure modulation in a single device; these dosimetric and integrative benefits are design expectations not yet experimentally tested. Conclusion: These concepts may improve local control where recurrence concentrates near the resection or stented surface, as in post-resection glioblastoma and obstructive luminal malignancies. The integration of continuous hyperthermia, local diffusion of chemotherapeutic, immunotherapeutic, and protective agents, and pressure-modulated nanoparticle delivery is particularly attractive. The concepts are intended to stimulate further bench, computational, animal, and clinical investigation.

Indexed as

brachytherapyesophageal stentglioblastomainterstitial hyperthermiaintracavitary radiation therapylocal drug deliverymedical device designradiation dose

Identifiers

PMID42620561
PMCPMC13485591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.